speb/financial-data huggingface dataset:
CHRS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3699000.00
CHRS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -190750000.00
CHRS income_statement (annual, 2022-12-31) — Research And Development: 199358000.00
CHRS balance_sheet (annual, 2022-12-31) — Retained Earnings: -1341608000.00
CHRS cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CHRS cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CHRS cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CHRS income_statement (annual, 2022-12-31) — Selling General And Administration: 198481000.00
CHRS balance_sheet (annual, 2022-12-31) — Share Issued: 78851516.00
CHRS income_statement (annual, 2022-12-31) — Special Income Charges: -6222000.00
CHRS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 50737000.00
CHRS balance_sheet (annual, 2022-12-31) — Stockholders Equity: -137418000.00
CHRS balance_sheet (annual, 2022-12-31) — Tangible Book Value: -143349000.00
CHRS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (annual, 2022-12-31) — Tax Provision: 0.00
CHRS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (annual, 2022-12-31) — Total Assets: 480847000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Capitalization: 333640000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Debt: 480422000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -137418000.00
CHRS income_statement (annual, 2022-12-31) — Total Expenses: 467922000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 618265000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 99613000.00
CHRS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 479571000.00
CHRS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -256880000.00
CHRS income_statement (annual, 2022-12-31) — Total Unusual Items: -6222000.00
CHRS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -6222000.00
CHRS balance_sheet (annual, 2022-12-31) — Working Capital: 242540000.00
CHRS income_statement (annual, 2023-12-31) — +Operating Expense: 301451000.00
CHRS income_statement (annual, 2023-12-31) — +Total Revenue: 257244000.00
CHRS balance_sheet (annual, 2023-12-31) — Accounts Payable: 35219000.00
CHRS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 260522000.00
CHRS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -20651000.00
CHRS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1386312000.00
CHRS cash_flow (annual, 2023-12-31) — Amortization Of Securities: -3052000.00
CHRS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 52595000.00
CHRS income_statement (annual, 2023-12-31) — Basic Average Shares: 94162637.00
CHRS income_statement (annual, 2023-12-31) — Basic EPS: -2.53
CHRS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 63987000.00
CHRS cash_flow (annual, 2023-12-31) — Capital Expenditure: -286000.00
CHRS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 7473000.00
CHRS balance_sheet (annual, 2023-12-31) — Capital Stock: 11000.00
CHRS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 102891000.00
CHRS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 117748000.00
CHRS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 69600000.00
CHRS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 144640000.00
CHRS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -174884000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Account Payable: 23760000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 118649000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Inventory: -46734000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Payable: 23760000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 142409000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 18182000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Receivables: -150683000.00
CHRS cash_flow (annual, 2023-12-31) — Change In Working Capital: -36826000.00
CHRS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -150683000.00
CHRS cash_flow (annual, 2023-12-31) — Changes In Cash: 39356000.00
CHRS balance_sheet (annual, 2023-12-31) — Common Stock: 11000.00
CHRS balance_sheet (annual, 2023-12-31) — Common Stock Equity: -193425000.00
CHRS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 71718000.00
CHRS balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
CHRS income_statement (annual, 2023-12-31) — Cost Of Revenue: 158992000.00
CHRS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 272886000.00
CHRS balance_sheet (annual, 2023-12-31) — Current Assets: 475631000.00
CHRS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 2145000.00
CHRS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2145000.00
CHRS balance_sheet (annual, 2023-12-31) — Current Liabilities: 331771000.00
CHRS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3791000.00
CHRS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3791000.00
CHRS income_statement (annual, 2023-12-31) — Diluted Average Shares: 94162637.00
CHRS income_statement (annual, 2023-12-31) — Diluted EPS: -2.53
CHRS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -237892000.00
CHRS income_statement (annual, 2023-12-31) — EBIT: -197730000.00
CHRS income_statement (annual, 2023-12-31) — EBITDA: -193939000.00
CHRS cash_flow (annual, 2023-12-31) — End Cash Position: 103343000.00
CHRS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 69600000.00
CHRS cash_flow (annual, 2023-12-31) — Free Cash Flow: -174884000.00
CHRS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 375000.00
CHRS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CHRS income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -248000.00
CHRS balance_sheet (annual, 2023-12-31) — Goodwill: 943000.00
CHRS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 71673000.00
CHRS balance_sheet (annual, 2023-12-31) — Gross PPE: 25770000.00
CHRS income_statement (annual, 2023-12-31) — Gross Profit: 98252000.00
CHRS income_statement (annual, 2023-12-31) — Interest Expense: 40542000.00
CHRS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 40542000.00
CHRS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 37857000.00
CHRS balance_sheet (annual, 2023-12-31) — Inventory: 62605000.00
CHRS balance_sheet (annual, 2023-12-31) — Invested Capital: 279944000.00
CHRS cash_flow (annual, 2023-12-31) — Investing Cash Flow: 144640000.00
CHRS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 71718000.00
CHRS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Leases: 5751000.00
CHRS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 5328000.00
CHRS balance_sheet (annual, 2023-12-31) — Long Term Debt: 473369000.00
CHRS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 478697000.00
CHRS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CHRS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 17725000.00
CHRS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 6997000.00
CHRS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 71718000.00
CHRS balance_sheet (annual, 2023-12-31) — Net Debt: 370478000.00
CHRS income_statement (annual, 2023-12-31) — Net Income: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -237892000.00
CHRS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -237892000.00
CHRS income_statement (annual, 2023-12-31) — Net Interest Income: -40542000.00
CHRS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 138135000.00
CHRS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
CHRS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
CHRS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -40542000.00
CHRS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -4621000.00
CHRS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -492000.00
CHRS balance_sheet (annual, 2023-12-31) — Net PPE: 5119000.00
CHRS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 559000.00
CHRS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -265098000.00
CHRS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (annual, 2023-12-31) — Normalized EBITDA: -193939000.00
CHRS income_statement (annual, 2023-12-31) — Normalized Income: -237892000.00
CHRS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -174884000.00
CHRS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 375000.00
CHRS income_statement (annual, 2023-12-31) — Operating Income: -203199000.00
CHRS income_statement (annual, 2023-12-31) — Operating Revenue: 257244000.00
CHRS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 112215260.00
CHRS balance_sheet (annual, 2023-12-31) — Other Current Assets: 11099000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -248000.00
CHRS income_statement (annual, 2023-12-31) — Other Income Expense: 5469000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 70730000.00
CHRS cash_flow (annual, 2023-12-31) — Other Non Cash Items: -37000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 77181000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 11459000.00
CHRS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 5469000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Properties: 2294000.00
CHRS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 14857000.00
CHRS balance_sheet (annual, 2023-12-31) — Payables: 35219000.00
CHRS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 308105000.00
CHRS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 21521000.00
CHRS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 23657000.00
CHRS income_statement (annual, 2023-12-31) — Pretax Income: -238272000.00
CHRS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2503000.00
CHRS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CHRS cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CHRS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -19507000.00
CHRS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -286000.00
CHRS balance_sheet (annual, 2023-12-31) — Receivables: 260522000.00
CHRS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 158992000.00
CHRS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3791000.00
CHRS cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
CHRS income_statement (annual, 2023-12-31) — Research And Development: 109436000.00
CHRS balance_sheet (annual, 2023-12-31) — Retained Earnings: -1579500000.00
CHRS cash_flow (annual, 2023-12-31) — Sale Of Business: 6997000.00
CHRS cash_flow (annual, 2023-12-31) — Sale Of Investment: 157642000.00
CHRS cash_flow (annual, 2023-12-31) — Sale Of PPE: 845000.00
CHRS income_statement (annual, 2023-12-31) — Selling General And Administration: 192015000.00
CHRS balance_sheet (annual, 2023-12-31) — Share Issued: 112215260.00
CHRS income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CHRS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 43110000.00
CHRS balance_sheet (annual, 2023-12-31) — Stockholders Equity: -193425000.00
CHRS balance_sheet (annual, 2023-12-31) — Tangible Book Value: -265098000.00
CHRS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (annual, 2023-12-31) — Tax Provision: -380000.00
CHRS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Total Assets: 629604000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Capitalization: 279944000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Debt: 480842000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -193425000.00
CHRS income_statement (annual, 2023-12-31) — Total Expenses: 460443000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 823029000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 153973000.00
CHRS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 491258000.00
CHRS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -203199000.00
CHRS income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CHRS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CHRS balance_sheet (annual, 2023-12-31) — Working Capital: 143860000.00
CHRS income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: -1086000.00
CHRS balance_sheet (quarterly, 2024-09-30) — Goodwill: 0.00
CHRS cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: -141000.00
CHRS cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: -141000.00
CHRS cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
CHRS cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
CHRS balance_sheet (quarterly, 2024-09-30) — Net Debt: 166819000.00
CHRS cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: -141000.00
CHRS cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -141000.00
CHRS cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 291000.00
CHRS cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
CHRS cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
CHRS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CHRS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
CHRS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CHRS income_statement (annual, 2024-12-31) — +Operating Expense: 217315000.00
CHRS income_statement (annual, 2024-12-31) — +Total Revenue: 26389000.00
CHRS balance_sheet (annual, 2024-12-31) — Accounts Payable: 28456000.00
CHRS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 111324000.00
CHRS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -20988000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -20988000.00
CHRS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1419266000.00
CHRS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 20915000.00
CHRS cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 11662000.00
CHRS balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 72180000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 72180000.00
CHRS income_statement (annual, 2024-12-31) — Basic Average Shares: 114553537.00
CHRS income_statement (annual, 2024-12-31) — Basic EPS: 0.25
CHRS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 103343000.00
CHRS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4977000.00
CHRS balance_sheet (annual, 2024-12-31) — Capital Stock: 12000.00
CHRS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 125987000.00
CHRS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 125987000.00
CHRS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -186974000.00
CHRS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 230321000.00
CHRS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -20440000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Account Payable: -3938000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -61392000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Inventory: -31952000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Payable: -3938000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -65330000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3826000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Receivables: 149350000.00
CHRS cash_flow (annual, 2024-12-31) — Change In Working Capital: 55894000.00
CHRS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 149350000.00
CHRS cash_flow (annual, 2024-12-31) — Changes In Cash: 22907000.00
CHRS balance_sheet (annual, 2024-12-31) — Common Stock: 12000.00
CHRS balance_sheet (annual, 2024-12-31) — Common Stock Equity: -131990000.00
CHRS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1455000.00
CHRS income_statement (annual, 2024-12-31) — Cost Of Revenue: 8727000.00
CHRS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 220870000.00
CHRS balance_sheet (annual, 2024-12-31) — Current Assets: 341583000.00
CHRS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1691000.00
CHRS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1691000.00
CHRS balance_sheet (annual, 2024-12-31) — Current Liabilities: 282981000.00
CHRS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5276000.00
CHRS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 5276000.00
CHRS income_statement (annual, 2024-12-31) — Diluted Average Shares: 114830462.00
CHRS income_statement (annual, 2024-12-31) — Diluted EPS: 0.25
CHRS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 28507000.00
CHRS income_statement (annual, 2024-12-31) — EBIT: -204660000.00
CHRS income_statement (annual, 2024-12-31) — EBITDA: -199384000.00
CHRS cash_flow (annual, 2024-12-31) — End Cash Position: 126250000.00
CHRS cash_flow (annual, 2024-12-31) — Financing Cash Flow: -186974000.00
CHRS cash_flow (annual, 2024-12-31) — Free Cash Flow: -20440000.00
CHRS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 5043000.00
CHRS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -176589000.00
CHRS cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 57000.00
CHRS income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 176589000.00
CHRS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: -57000.00
CHRS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -275000.00
CHRS balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
CHRS balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 53646000.00
CHRS balance_sheet (annual, 2024-12-31) — Gross PPE: 23564000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 23564000.00
CHRS income_statement (annual, 2024-12-31) — Gross Profit: 17662000.00
CHRS income_statement (annual, 2024-12-31) — Interest Expense: 10734000.00
CHRS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 10734000.00
CHRS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 25376000.00
CHRS balance_sheet (annual, 2024-12-31) — Inventory: 4207000.00
CHRS balance_sheet (annual, 2024-12-31) — Invested Capital: 132937000.00
CHRS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 230321000.00
CHRS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1455000.00
CHRS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 36979000.00
CHRS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Leases: 5751000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Leases: 5751000.00
CHRS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3286000.00
CHRS balance_sheet (annual, 2024-12-31) — Long Term Debt: 264927000.00
CHRS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 268213000.00
CHRS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 36979000.00
CHRS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CHRS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -260387000.00
CHRS cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 18074000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 18074000.00
CHRS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 215323000.00
CHRS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -12500000.00
CHRS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1455000.00
CHRS balance_sheet (annual, 2024-12-31) — Net Debt: 138940000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Net Debt: 138940000.00
CHRS income_statement (annual, 2024-12-31) — Net Income: 28507000.00
CHRS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 28507000.00
CHRS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -215394000.00
CHRS income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 243901000.00
CHRS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 28507000.00
CHRS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -215394000.00
CHRS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 28507000.00
CHRS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 28507000.00
CHRS income_statement (annual, 2024-12-31) — Net Interest Income: -10734000.00
CHRS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 14888000.00
CHRS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -223408000.00
CHRS cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CHRS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -223408000.00
CHRS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CHRS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -10734000.00
CHRS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 34053000.00
CHRS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 110000.00
CHRS balance_sheet (annual, 2024-12-31) — Net PPE: 2576000.00
CHRS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -185636000.00
CHRS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (annual, 2024-12-31) — Normalized EBITDA: -186754000.00
CHRS income_statement (annual, 2024-12-31) — Normalized Income: -202764000.00
CHRS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -20440000.00
CHRS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -158916000.00
CHRS cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 5100000.00
CHRS income_statement (annual, 2024-12-31) — Operating Income: -199653000.00
CHRS income_statement (annual, 2024-12-31) — Operating Revenue: 26389000.00
CHRS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 115614548.00
CHRS balance_sheet (annual, 2024-12-31) — Other Current Assets: 10222000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 13620000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -275000.00
CHRS income_statement (annual, 2024-12-31) — Other Income Expense: -5007000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 53646000.00
CHRS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 82000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 50728000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 28227000.00
CHRS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 7623000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Properties: -261000.00
CHRS balance_sheet (quarterly, 2024-12-31) — Other Properties: -261000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Receivables: 11010000.00
CHRS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CHRS balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
CHRS income_statement (annual, 2024-12-31) — Other Special Charges: 12630000.00
CHRS income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Payables: 28456000.00
CHRS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 249326000.00
CHRS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 18344000.00
CHRS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 6653000.00
CHRS income_statement (annual, 2024-12-31) — Pretax Income: -215394000.00
CHRS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 926000.00
CHRS cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 241000.00
CHRS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CHRS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CHRS cash_flow (annual, 2024-12-31) — Purchase Of Business: -12500000.00
CHRS cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Receivables: 122334000.00
CHRS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 8727000.00
CHRS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5276000.00
CHRS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -260387000.00
CHRS cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
CHRS income_statement (annual, 2024-12-31) — Research And Development: 91833000.00
CHRS balance_sheet (annual, 2024-12-31) — Retained Earnings: -1550993000.00
CHRS cash_flow (annual, 2024-12-31) — Sale Of Business: 227823000.00
CHRS cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
CHRS cash_flow (annual, 2024-12-31) — Sale Of Investment: 14888000.00
CHRS income_statement (annual, 2024-12-31) — Selling General And Administration: 125482000.00
CHRS balance_sheet (annual, 2024-12-31) — Share Issued: 115614548.00
CHRS income_statement (annual, 2024-12-31) — Special Income Charges: -12630000.00
CHRS income_statement (quarterly, 2024-12-31) — Special Income Charges: -57000.00
CHRS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 27802000.00
CHRS balance_sheet (annual, 2024-12-31) — Stockholders Equity: -131990000.00
CHRS balance_sheet (annual, 2024-12-31) — Tangible Book Value: -185636000.00
CHRS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CHRS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (annual, 2024-12-31) — Total Assets: 448533000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Capitalization: 132937000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Debt: 269904000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -131990000.00
CHRS income_statement (annual, 2024-12-31) — Total Expenses: 226042000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 580523000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 106950000.00
CHRS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 297542000.00
CHRS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -199653000.00
CHRS income_statement (annual, 2024-12-31) — Total Unusual Items: -12630000.00
CHRS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -57000.00
CHRS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -12630000.00
CHRS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -57000.00
CHRS balance_sheet (annual, 2024-12-31) — Working Capital: 58602000.00
CHRS income_statement (quarterly, 2025-03-31) — +Operating Expense: 50381000.00
CHRS income_statement (quarterly, 2025-03-31) — +Total Revenue: 7599000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 40930000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 60488000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -21368000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1424355000.00
CHRS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 138972000.00
CHRS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 115857780.00
CHRS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.49
CHRS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 126250000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4577000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 82411000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 82411000.00
CHRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -264000.00
CHRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -17486000.00
CHRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -25826000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 13042000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -23848000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -22244000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1836000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Payable: 13042000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -10806000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -5146000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 50891000.00
CHRS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 10859000.00
CHRS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 50891000.00
CHRS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -43576000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Common Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -183470000.00
CHRS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CHRS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2653000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 166011000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Current Assets: 310175000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1723000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1723000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 255042000.00
CHRS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1046000.00
CHRS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1046000.00
CHRS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 115857780.00
CHRS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.49
CHRS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — EBIT: -45248000.00
CHRS income_statement (quarterly, 2025-03-31) — EBITDA: -44202000.00
CHRS cash_flow (quarterly, 2025-03-31) — End Cash Position: 82674000.00
CHRS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -264000.00
CHRS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -25826000.00
CHRS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 12608000.00
CHRS cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -275000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 52979000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 23624000.00
CHRS income_statement (quarterly, 2025-03-31) — Gross Profit: 4946000.00
CHRS income_statement (quarterly, 2025-03-31) — Interest Expense: 2150000.00
CHRS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2150000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Inventory: 3518000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 81880000.00
CHRS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -17486000.00
CHRS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Leases: 5751000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2854000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 265350000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 268204000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 18128000.00
CHRS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Net Debt: 182939000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -47398000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -9171000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -47398000.00
CHRS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -56569000.00
CHRS income_statement (quarterly, 2025-03-31) — Net Interest Income: -2150000.00
CHRS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CHRS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2150000.00
CHRS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -264000.00
CHRS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -17486000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2256000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -236449000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -44202000.00
CHRS income_statement (quarterly, 2025-03-31) — Normalized Income: -47398000.00
CHRS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -25826000.00
CHRS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 12608000.00
CHRS income_statement (quarterly, 2025-03-31) — Operating Income: -45435000.00
CHRS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7348000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 115907216.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 15930000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 26300000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -275000.00
CHRS income_statement (quarterly, 2025-03-31) — Other Income Expense: 187000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 52979000.00
CHRS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 858000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5656000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 30188000.00
CHRS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 187000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Payable: 128000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Properties: -255000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1948000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Payables: 41058000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 207069000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 19950000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6908000.00
CHRS income_statement (quarterly, 2025-03-31) — Pretax Income: -47398000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CHRS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Receivables: 62436000.00
CHRS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2653000.00
CHRS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1046000.00
CHRS income_statement (quarterly, 2025-03-31) — Research And Development: 24356000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1607562000.00
CHRS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CHRS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 26025000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Share Issued: 115907216.00
CHRS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5372000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -183470000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -236449000.00
CHRS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CHRS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Assets: 371066000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 81880000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Debt: 269927000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -183470000.00
CHRS income_statement (quarterly, 2025-03-31) — Total Expenses: 53034000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 554536000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 60891000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 299494000.00
CHRS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -45435000.00
CHRS balance_sheet (quarterly, 2025-03-31) — Working Capital: 55133000.00
CHRS income_statement (quarterly, 2025-06-30) — +Operating Expense: 52345000.00
CHRS income_statement (quarterly, 2025-06-30) — +Total Revenue: 10254000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 37622000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 5109000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -19058000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1429885000.00
CHRS cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CHRS balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 116077710.00
CHRS income_statement (quarterly, 2025-06-30) — Basic EPS: 2.57
CHRS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 82674000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4162000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 216893000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 237637000.00
CHRS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -281524000.00
CHRS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 462638000.00
CHRS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -46632000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -12209000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -66445000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Inventory: 3770000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -8711000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Payable: -12209000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -78654000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 4673000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 55270000.00
CHRS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -23652000.00
CHRS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 55270000.00
CHRS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 134482000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Common Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 119827000.00
CHRS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3395000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 213236000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Current Assets: 380205000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1756000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1756000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 265119000.00
CHRS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1016000.00
CHRS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1016000.00
CHRS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 116077710.00
CHRS income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.57
CHRS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — EBIT: -42585000.00
CHRS income_statement (quarterly, 2025-06-30) — EBITDA: -41569000.00
CHRS cash_flow (quarterly, 2025-06-30) — End Cash Position: 217156000.00
CHRS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -281524000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Finished Goods: 4513000.00
CHRS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -46632000.00
CHRS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CHRS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: -339102000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -275000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 52312000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 20965000.00
CHRS income_statement (quarterly, 2025-06-30) — Gross Profit: 6859000.00
CHRS income_statement (quarterly, 2025-06-30) — Interest Expense: 2277000.00
CHRS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2277000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Inventory: 4513000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 156694000.00
CHRS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 462638000.00
CHRS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CHRS balance_sheet (quarterly, 2025-06-30) — Leases: 5752000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2406000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 36867000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 39273000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 15213000.00
CHRS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -44862000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 342629000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -44862000.00
CHRS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 297767000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2277000.00
CHRS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -20726000.00
CHRS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2277000.00
CHRS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -48527000.00
CHRS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 4683000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Net PPE: 1907000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 67515000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -41569000.00
CHRS income_statement (quarterly, 2025-06-30) — Normalized Income: -44862000.00
CHRS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -46632000.00
CHRS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -328816000.00
CHRS income_statement (quarterly, 2025-06-30) — Operating Income: -45486000.00
CHRS income_statement (quarterly, 2025-06-30) — Operating Revenue: 10254000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 116222726.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 11716000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1490000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -275000.00
CHRS income_statement (quarterly, 2025-06-30) — Other Income Expense: 2901000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 52312000.00
CHRS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1632000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5040000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 14143000.00
CHRS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2901000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 114530000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 20744000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Payables: 37622000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 250858000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 11015000.00